Gene-Editing Company Beam Seeks $100 Million IPO

Gene-Editing Company Beam Seeks $100 Million IPO

Submitted by admin on September 30, 2019 - 11:40pm
Source: 
BioSpace
News Tags: 
Beam Therapeutics
IPOs
gene editing
Headline: 
Gene-Editing Company Beam Seeks $100 Million IPO
snippet: 

Beam, which is one of BioSpace’s NextGen Bio “Class of 2019” Life Science Startups to Watch in 2019, filed its IPO plans with the U.S. Securities and Exchange Commission on Friday.

Do Not Allow Advertisers to Use My Personal information